NeuroOne Medical Technologies Corporation Deferred Tax Assets, Operating Loss Carryforwards, Domestic
NeuroOne Medical Technologies Corporation (NMTC) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $35.41 million as of 2022-09-30, per its 10-K filed 2022-12-22.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2022-12-22
- 2022-09-30: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $35.41M.
- 2021-09-30: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $26.36M.
- 2020-09-30: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $17.18M.
- 2019-09-30: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $12.28M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2022-09-30 | $35.41M 10-K · filed 2022-12-22 |
| 2021-09-30 | $26.36M 10-K · filed 2022-12-22 |
| 2020-09-30 | $17.18M 10-K/A · filed 2022-05-31 |
| 2019-09-30 | $12.28M 10-K · filed 2020-12-09 |
| 2018-09-30 | $6.39M 10-K · filed 2019-12-20 |
| 2017-12-31 | $3.03M 10-KT · filed 2019-03-18 |
| 2016-12-31 | $186.00K 10-K · filed 2018-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |